PolarityTE (PTEIQ) Competitors $0.15 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock PTEIQ vs. MYMD, EVOK, VRAX, SONN, IMCC, CELZ, MAAQ, PPBT, SNPX, and NBYShould you be buying PolarityTE stock or one of its competitors? The main competitors of PolarityTE include MyMD Pharmaceuticals (MYMD), Evoke Pharma (EVOK), Virax Biolabs Group (VRAX), Sonnet BioTherapeutics (SONN), IM Cannabis (IMCC), Creative Medical Technology (CELZ), Mana Capital Acquisition (MAAQ), Purple Biotech (PPBT), Synaptogenix (SNPX), and NovaBay Pharmaceuticals (NBY). These companies are all part of the "pharmaceutical products" industry. PolarityTE vs. MyMD Pharmaceuticals Evoke Pharma Virax Biolabs Group Sonnet BioTherapeutics IM Cannabis Creative Medical Technology Mana Capital Acquisition Purple Biotech Synaptogenix NovaBay Pharmaceuticals PolarityTE (NASDAQ:PTEIQ) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, community ranking, analyst recommendations, media sentiment and institutional ownership. Does the MarketBeat Community prefer PTEIQ or MYMD? PolarityTE and MyMD Pharmaceuticals both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPolarityTEN/AN/AMyMD PharmaceuticalsN/AN/A Is PTEIQ or MYMD more profitable? PolarityTE's return on equity of -106.08% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets PolarityTEN/A -106.08% -76.91% MyMD Pharmaceuticals N/A -179.05%-108.14% Does the media refer more to PTEIQ or MYMD? In the previous week, PolarityTE's average media sentiment score of 0.00 equaled MyMD Pharmaceuticals'average media sentiment score. Company Overall Sentiment PolarityTE Neutral MyMD Pharmaceuticals Neutral Which has preferable valuation & earnings, PTEIQ or MYMD? MyMD Pharmaceuticals has lower revenue, but higher earnings than PolarityTE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarityTE$810K1.36-$7.83M-$3.28-0.05MyMD PharmaceuticalsN/AN/A-$4MN/AN/A Do insiders and institutionals hold more shares of PTEIQ or MYMD? 11.8% of PolarityTE shares are owned by institutional investors. Comparatively, 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. 5.4% of PolarityTE shares are owned by company insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, PTEIQ or MYMD? PolarityTE has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. SummaryPolarityTE beats MyMD Pharmaceuticals on 5 of the 7 factors compared between the two stocks. Remove Ads Get PolarityTE News Delivered to You Automatically Sign up to receive the latest news and ratings for PTEIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTEIQ vs. The Competition Export to ExcelMetricPolarityTEBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.10M$108.24M$5.64B$7.79BDividend YieldN/A3.78%5.34%4.03%P/E Ratio-0.053.1023.6318.68Price / Sales1.364,104.44370.1589.76Price / CashN/A12.7538.1734.64Price / Book0.0735.866.744.12Net Income-$7.83M-$91.48M$3.20B$247.10M7 Day PerformanceN/A-4.09%-5.63%-3.81%1 Month Performance0.07%57.53%-0.38%-6.23%1 Year PerformanceN/A81.51%7.72%-1.89% PolarityTE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTEIQPolarityTEN/A$0.15flatN/A+50.3%$1.10M$810,000.00-0.0560MYMDMyMD PharmaceuticalsN/A$0.36+0.5%N/A-84.9%$4.31MN/A0.006EVOKEvoke Pharma0.724 of 5 stars$2.88+2.5%N/A-62.4%$4.30M$10.25M-0.264Short Interest ↓VRAXVirax Biolabs Group3.1958 of 5 stars$1.27-1.6%N/A+59.0%$4.11M$84,872.000.005Analyst ForecastShort Interest ↓News CoveragePositive NewsGap UpSONNSonnet BioTherapeutics2.1501 of 5 stars$1.33-2.2%$20.00+1,403.8%-28.0%$4.08M$1M0.0010IMCCIM Cannabis1.4336 of 5 stars$1.76-1.9%N/A-52.5%$4.01M$51.39M-0.52340Short Interest ↓News CoverageCELZCreative Medical Technology1.398 of 5 stars$2.21+0.5%N/A-58.3%$3.86M$11,000.00-0.585High Trading VolumeMAAQMana Capital AcquisitionN/A$0.45+2.3%N/A-73.3%$3.66MN/A0.001High Trading VolumePPBTPurple Biotech2.0695 of 5 stars$2.74-2.5%$33.00+1,104.4%N/A$3.65MN/A-0.3120SNPXSynaptogenix2.1614 of 5 stars$2.63+2.2%$14.00+433.1%-48.4%$3.56MN/A0.004Earnings ReportUpcoming EarningsNBYNovaBay Pharmaceuticals1.5393 of 5 stars$0.61flat$0.85+39.3%-84.0%$3.55M$13.84M-0.0130 Remove Ads Related Companies and Tools Related Companies MyMD Pharmaceuticals Competitors Evoke Pharma Competitors Virax Biolabs Group Competitors Sonnet BioTherapeutics Competitors IM Cannabis Competitors Creative Medical Technology Competitors Mana Capital Acquisition Competitors Purple Biotech Competitors Synaptogenix Competitors NovaBay Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTEIQ) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolarityTE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolarityTE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTEIQ Stock Free PTEIQ Stock Alerts